The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Lacosamide Eignapharma 10 mg/ml syrup

Neuraxpharm Ireland LimitedPA23229/004/001

Main Information

Trade NameLacosamide Eignapharma 10 mg/ml syrup
Active SubstancesLacosamide
Dosage FormSyrup
Licence HolderNeuraxpharm Ireland Limited
Licence NumberPA23229/004/001

Group Information

ATC CodeN03AX18 lacosamide


License statusAuthorised
Licence Issued29/10/2021
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available
« Back